Stay Updated with the Latest Genscript Biotech Corporation 1548.HK News in Real Time
Find 1548.HK news now at Meyka AI. Stay informed with the latest Genscript Biotech Corporation stocks updates, including price news, market analysis, and expert insights.
S&P 500, Dow Futures Rise Despite Big Tech Losses and Hot Inflation; AAPL, MSFT, BABA in Focus
U.S. stock market futures edged higher on June 27, 2026, even as major technology stocks faced renewed selling pressure and fresh inflation data came in hotter-than-expected. The surprising market resilience has shifted investors’ attention to whether the broader rally can continue despite concerns over interest rates. At the center of the action are Apple (AAPL),…
IBM Shares Waver After Unveiling Fingernail-Sized AI Chip
IBM drew global attention on June 25, 2026, after unveiling a fingernail-sized AI chip designed to deliver faster computing while using less power. The breakthrough marks another step in the race to build more efficient AI hardware. Yet the company’s shares showed mixed movement as investors looked beyond the innovation and focused on its commercial…
Dutch Court Clears Class-Action Suit Against Sony Over PlayStation Store Pricing
Sony Group Corporation (NYSE: SONY) faces a major legal challenge in Europe. A court in the Netherlands validated a class-action claim against Sony over prices for PlayStation games and will take up the lawsuit from June 29. Stichting Massaschade & Consument was authorized to represent around 1.7 million PlayStation players in the country. The group…
NVDA Stock Rises 0.8% in Early Market as AEGON Asset Management UK Plc Sells 176,898 Shares of NVIDIA Corporation
NVDA stock opened with quiet resilience on June 25, 2026, rising approximately 0.8% in early trading. NVIDIA’s opening price was $202.17, with the day’s range spanning $200.00 to $203.77. The modest gain came alongside a disclosed institutional trim. AEGON Asset Management UK Plc lessened its position in NVIDIA Corporation (NASDAQ: NVDA) by 5.6% in the…
Avience Biomedicals Ltd Share Price Jumps 90%: Stock Lists at ₹395.20 on NSE SME After IPO at ₹208
Avience Biomedicals Ltd (NSE SME: AVIENCE) delivered one of the standout SME debuts of 2026. The IPO was priced at ₹208 per share, with a price band of ₹196 to ₹208. On June 25, 2026, the stock listed at ₹395.20 on NSE SME Emerge, a gain of approximately 90% over the issue price. The debut…
Take-Two Sets GTA VI Release for PS5 and Xbox Series X|S on November 19, 2026 at $79.99
GTA VI has a firm price and a launch date. Take-Two Interactive confirmed on June 24, 2026, that Grand Theft Auto VI will launch on November 19 at $79.99 for PS5 and Xbox Series X|S. TTWO stock climbed roughly 3% in premarket trading after the announcement, with Bank of America simultaneously raising its price target…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Birla Corporation (NSE: BIRLACORPN ) Shares Jump 4% After Commercial Operations Begin at Bikram Coal Mine
Birla Corporation (NSE: BIRLACORPN) delivered a sharp 4% stock gain after officially commencing coal mining at its Bikram Coal Mine in Burhar, Shahdol, Madhya Pradesh on April 23, 2026, at 12:32 PM IST. The disclosure was filed under SEBI Regulation 30. The mine holds 9.44 million tonnes of extractable G8-grade thermal coal reserves, with a…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…